In this study, inter-pulmonary administration of Bleomycin is carried out by nasal nebulization to create a mouse model of pulmonary fibrosis that closely mimic clinical disease characteristics. After anesthetizing the mouse press its toes with the index finger and thumb to ensure the limb withdrawal reflects has disappeared. Once the instrument is calibrated, secure the anesthetized mouse with a soft mesh cover.
Using a pipette, add the working BLM solution to the top atomizing head of the exposure tower, and run the nebulizer for 30 minutes to achieve stable atomization. Now double click the FlexiWare 8 icon. Select the Experimentation Session and click the New Study button.
Edit the Experiment Name, Title, and Owner. Then choose the IX-4DIO template. Input the operator and click the Confirm button.
Click Next In the Welcome window. In the Pump Selection window, choose the Pump tab and click Next. It leads to the window named, Test set-up-Pump 4.
Click the Next button and the Pump Output Adjustment window will pop up, and click Next again. Then click the Finish button in the Results-Pump 4 window. Click on the settings for Continuous 1L/min.
Select DIO1 and set the Duty Cycle to 25%Then click OK and set the Duty Cycle percent for DIO2, DIO3, and DIO4. Now start the procedure by clicking the top green button and stop by clicking the red button. Click X at the top right corner to quit.
The BLM administered mice lungs displayed diffused pneumonic lesions with loss of the normal alveolar architecture, septal thickening, enlarged alveoli, and increased infiltration of inflammatory cells into the Interstitial and Peribronchiolar areas, compared to the control group. The Ashcroft scores for the BLM mice on the 9th, 16th and 23rd days, were higher than those in the control group. The aerosolized the particle with 2.5 to four micrometer in size, which enable Bleomycin to distribute evenly throughout the lung and that reach the subpleural area.